Description:
IRAK4-IN-3 is a compound with exceptional potency and selectivity against interleukin-1 receptor-associated kinase 4 (IRAK4), an inflammation-linked kinase. This compound has displayed tremendous promise in the treatment of autoimmune conditions, including rheumatoid arthritis and systemic lupus erythematosus. As such, it represents a significant advance in the field of molecular therapeutics targeting inflammatory disorders.
- Molecular Weight: 385.5
- Molecular Formula: C21H31N5O2
Canonical SMILES:
C1CC(CCC1NC2=NC=NC3=C2C(=CN3)C4CCOCC4)N5CCOCC5
InChI:
InChI=1S/C21H31N5O2/c1-3-17(26-7-11-28-12-8-26)4-2-16(1)25-21-19-18(15-5-9-27-10-6-15)13-22-20(19)23-14-24-21/h13-17H,1-12H2,(H2,22,23,24,25)
InChIKey: DJVYXMINSBMUHH-UHFFFAOYSA-NSynonyms:
IRAK4-IN-3 is an IRAK4 inhibitor.
More details are to be found on supplier website
